News

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...
Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) without considering cardiovascular and kidney risks, according to a BMJ ...
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...
More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...